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Abstract:
The current level of health spending in the U.S. is the highest in the world. However, the
outcomes of the health spending are among the lowest for developed countries. Therefore,
for policy development purpose, it is necessary to determine which direction of healthcare
spending results in better output, private or public. This paper investigates the effect of
private and public health expenditure on life expectancy, infant mortality at birth, and
infant mortality under age 5 among 11 OECD countries. Hausman test is performed to
confirm the fixed effects models. Fixed effects GLS and GMM are used for data analysis.
We find that both public and private healthcare spending are not meaningful, but number
of physicians has great impact on health outcomes. Statistical insignificance and extremely
low coefficients of health spending variables signal over-spending and cost inflation issues
of healthcare. This may be especially true for the U.S. and might explain lackluster health
outcome despite the highest healthcare spending in the world.
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1.0 INTRODUCTION
Healthcare expenditure has been increasing for the past two decades worldwide. In
the United States, it has become a major factor of the GDP (almost 18%), which is the
highest among other OECD countries. There are two important categories of healthcare
expenditure: private and public. This study aims to enhance understanding of how private
and public spending on healthcare influences health outcomes, such as life expectancy
and infant mortality.
Most industrialized countries have national healthcare system or market regulation
that is able to provide service to almost all citizens. In fact, comparable countries such as
Switzerland and United Kingdom have 100% of their citizens insured. However, the United
States falls significantly below at 91.2% (Peterson-Kaiser, 2018). Ironically, the United
States spends the most on healthcare among other OECD countries. Hence, a key difference
in healthcare systems between the United States and other wealthy nations is that the
United States does not provide insurance programs for all citizens. With this difference,
there arises the question of whether the healthcare structure is efficient. Indeed, it is not
difficult to find evidence that the United States is at the bottom of the list when it comes to
healthcare efficiency (Miller & Lu, 2018).
The discussion about healthcare structure of the United States has been a constant
debate. Most notably, the Affordable Care Act was introduced in 2010 to increase public
provision of healthcare, but the current (2019) government favors more market driven
healthcare sector. The common argument for supporting capitalist structure of healthcare
system is that market can provide services efficiently to insureds and regulation will
disincentivize private companies from offering good quality healthcare to insureds.
Nevertheless, the apparent results have shown that the healthcare expenditure has soared
in the United States without being able to provide the service to almost 10% of its
population while citizens do not live longer than other OECD countries. At a glimpse,
market failure exists because the supply of healthcare does not meet the demand of the
population, which calls for government intervention. Moreover, healthcare being a
necessity asks for public provision as well.
Because the United States constantly undergoes healthcare reforms and struggles
to create a wholesome healthcare system that can cover more than 99% of the population,

it is critical to understand how healthcare spending can affect population health. More
specifically, it is necessary to realize the different impacts public and private health
expenditure have on health outcomes in order to create a policy that reflects more efficient
resource spending. Furthermore, it is crucial to investigate the limit of healthcare spending
where decreasing returns to scales begins.
Therefore, the research objectives are (1) reiterate the effects of private and public
healthcare spending on life expectancy, infant mortality, and mortality under age 5 with
recent data, and (2) investigate the implication of healthcare spending in the U.S.
The rest of the paper is organized as follows: Section 2 shows trends and section 3
gives a brief literature review. Section 4 outlines the data and empirical analysis. This is
followed by empirical results in section 5 and conclusion in section 6.

2.0 Trend

Figure 1: Private Health Expenditure (%GDP)

Source: Index Mundi https://www.indexmundi.com/facts/indicators/SH.XPD.PRIV.ZS

Figure 1 shows that the United States is one of the countries with the highest private
healthcare spending. Similarly, in Figure 2, public expenditure as a share of GDP of the
United States (14%) is the highest among the OECD countries.
Figure 2: Public Health Expenditure (%GDP)

Source: OECD Data https://data.oecd.org/healthres/health-spending.htm

While one might think high spending on health care from both private and public
sectors has increased average American’s quality of life, the health outcomes tell a different
story.
Figure 3: Life Expectancy at Birth

Source: OECD Data https://data.oecd.org/healthstat/life-expectancy-at-birth.htm

Figure 4: Infant Mortality

Source: OECD Data https://data.oecd.org/healthstat/infant-mortality-rates.htm

Both Figure 3 and Figure 4 exhibits that health outcome measured in life
expectancy and infant mortality are among the worse in the United States. The
discrepancy between high health spending and low health outcomes raise the questions of

whether private health expenditure or public health expenditure results in superior health
outcome than one another, and the possibility of low return on outcome beyond certain
level of healthcare expenditure.

3.0 LITERATURE REVIEW
Assessment of the relationship between healthcare spending and health outcome is
measuring the efficiency. This enables us to measure how well the resources, private and
public health expenditure, are spent by evaluating the output, mortality and life expectancy.
In many existing literatures, healthcare efficiency has been evaluated using Data
Envelopment Analysis (DEA), which is a non-parametric benchmarking tool. These
literatures (World Health Organization, 2018; de Cos & Moral-Benito, 2011) usually use
total healthcare expenditure, rather than separating them in private and public spending.
On the other hand, studies that do separate healthcare expenditure in private and public,
such as Rahman, Khanam, & Rahman (2018), Raeesi et al. (2018), and Tacke & Waldmann
(2011), generally use parametric models.
Measuring the difference between the effect of private and public healthcare
expenditure needs to be treated in another way than the common efficiency gauging
methods. Previously mentioned efficiency calculating technique, DEA, uses an entity with
the best combination of input and output as a benchmark. Using linear programming, other
entries that deviate from the benchmark are considered inefficient. Efficiency scores are
calculated for each input-output combination based on the deviation from the benchmark.
This technique could have been useful if the focus of this study was to rank countries based
on how efficiency they spend private and public healthcare. However, the scope of the
efficiency in this study’s objective is a different matter. The interest of this study is
observing how health outcome reacts to changes in private and public health spending,
which is not possible by simply scoring efficiency ratings.
The structure of healthcare system creates differences in how healthcare spending
impacts health outcomes (Raeesi et al., 2018). Raessi et al. (2018), categorizes healthcare
system into four types: National Health Insurance System offering health insurance at

national level, Traditional Sickness Insurance where state subsidy is present in private
insurance market, National Health Services which health care is provided by the country,
and Mixed Systems that has both traditional sickness insurance and national health
coverage. Depending on the structure of healthcare system, the impact of public and private
health expenditure on health outcomes change. Intuitively, in systems where government
regulation is less strict, private healthcare spending has greater impact on health outcomes.
In addition, Raessi et al. (2018) implies that more tightly controlled healthcare system is
more efficient than a system that is less tightly controlled. Raessi et al. (2018) provides
important information about how the effects of private and public healthcare spending can
differ based on the structure of the healthcare system.
On the other hand, an important issue arises when countries are categorized based
on their healthcare systems. It only allows you to analyze effectiveness of healthcare
spending structure among the countries in the same cohort. If the goal of a research is to
find which system performs better under public or private healthcare spending, classifying
the systems works well. However, if the goal is to compare the effectiveness of healthcare
spending regardless of the healthcare system, categorical data would not provide the
information the research is looking for. This is especially true when the research focus is
rather small group of developed countries. Sorting the countries result in small number of
observations, which is not desirable.
Therefore, to compare the United States with other developed countries, this study
uses fixed effects model to control for healthcare system differences in countries without
separating the countries.
Lastly, in comparing the healthcare system of Switzerland and the United States,
Cosgrove (2018) asserts that over-spending on healthcare insurance results in cost
inflation, which is the reason why Switzerland’s goal is to prevent its citizens from
spending more than 10% of their income on healthcare. Considering the high amount of
health expenditure of the United States, this imposes the possibility of healthcare cost
inflation.

4.0 EMPIRICAL METHODOLOGY
4.1 Data
Panel data from 2000 to 2016 is used for data analysis. There are 11 countries in total.
These countries are Australia, Canada, Switzerland, Germany, Denmark, France, the
United Kingdom, Japan, Netherlands, Sweden, and the United States. Data are collected
from the OECD and the World Development Indicator (WDI) websites. Variables used are
life expectancy at birth; infant mortality under age 1; infant mortality under age 5; public
health expenditure; private health expenditure, which is measured by adding voluntary and
out of pocket expenses; per capita income; and per capita physician per 1000 population.
Following Raessi et al. (2018), this study adapted their analytical framework,
without categorizing countries. First, Ordinary Least Squares method is used to perform
Hausman test and investigate whether fixed effects is appropriate for the model. Second,
Generalized Least Square method is performed for fixed effects model. Additionally,
Generalized Method of Moments is used to compare the results with GLS. Below is the
summary statistics.

4.2 Empirical Models
There are three models to consider. These models are used for Ordinary Least Squares
(OLS) and Generalized Least Squares estimation (GLS).
LE = a + B1PHE + B2PrHE + B3Y + B4PHY + e

(1)

IM = a + B1PHE + B2PrHE + B3Y + B4PHY + e

(2)

IM5 = a + B1PHE + B2PrHE + B3Y + B4PHY + e

(3)

Dependent variables are Life expectancy at birth (LE), Infant Mortality (IM),
Mortality under age 5 (IM5). Independent variables are Public Health
Expenditure %GDP (PHE), Private Health Expenditure %GDP (PrHE), Per Capita
Income (Y), Per Capita Physician per 1000 population (PHY).
Next, there are three models for Generalized Method of Moments (GMM)
estimation.
LE = LEi(t-1) + B1PHE + B2PrHE + Xit + e

(4)

IM = IMi(t-1) + B1PHE + B2PrHE + Xit + e

(5)

IM5 = IM5i(t-1) + B1PHE + B2PrHE + Xit + e

(6)

Variables are the same as OLS and GLS regressions. Here, lag of the dependent variables
and health expenditures are included as GMM instruments. X is a vector that includes per
capita income and number of physicians.
OLS and Hausman test are used to observe and confirm the fixed effects model.
GLS and GMM are performed to estimate and compare the effects of healthcare spending
on health outcomes between the two regression models.

5.0 Empirical Results

5.1 OLS
In Table 2, models 1, 3, and 5 are fixed effects models and models 2, 4, and 6 are
random effects models. Two models do not show any meaningful difference. Hausman
test results for the equations (1), (2), and (3) are 0, 0, and 0, respectively. This rejects the
null hypothesis that the unique errors are not correlated with the regressors and confirms
the usage of fixed effects models. In general, fixed effects model has more significant
variables than random effects models. R-squared is higher for fixed effects when the
dependent variables are mortality measures, but it is lower when the dependent variable is
life expectancy. Significant variables differ depending on the model. However, the
number of physicians is consistently significant for all models and may be the most
important factor.
Both kind of the health expenditure are simultaneously significant only when the
dependent variable is mortality under age 5. Furthermore, public health expenditure is
more statistically significant than private health expenditure under this model.
Nevertheless, it would be premature to conclude that the public health expenditure has
stronger impact on reducing the mortality, since our OLS results are not consistent.
In addition, Tables 3, 4, and 5 shows fixed effects coefficients for each country.
All countries’ coefficients are statistically significant. The United States’ coefficient for
the life expectancy is the smallest and highest for the mortality measures, which reiterates

the poor health performance of the United States compared to other developed countries.
5.2 Generalized Least Square (GLS)

Both OLS and GLS results show that number of physicians have greater impact
on all health outcomes in increasing life expectancy and decreasing mortality measures.
Perhaps, this signals that better access to healthcare is more effective in enhancing the
population health than spending more money for developed countries.

5.3 Generalized Method of Moments (GMM)

6.0 Conclusion & Policy Discussion
The limitation exists in that there may be omitted variables. It will be necessary to
further investigate the determinants of health outcomes for more robust analysis.
Nevertheless, we conclude that the effect of public and private health expenditure on
health outcomes should not be considered as meaningful. Statistical significance of health
spending is inconsistent throughout OLS and GMM models. Moreover, even though
health expenditures are statistically significant in GLS models, coefficients are extremely
small and negatively impacts health outcomes by decreasing life expectancy and
increasing infant mortalities.
On the other hand, the number of physicians per 1000 population has shown to be
statistically significant throughout most models, except for GLS model with life
expectancy as the dependent variable and GMM model with mortality under age 5 as the
dependent variable. In addition, coefficients for physician variable are significantly
higher for life expectancy and lower for mortality measures than all other variables.
The consistency of physician variable could be indicating that the increase in the
number of physician impact health outcomes much better than healthcare spending and
income per capita. This might be the case since the data consists of developed countries
that already have high healthcare spending and income. Furthermore, this could imply
that high healthcare spending already resulted in cost inflation, especially for the United
States. This is in align with the extremely small coefficients of health expenditures. This
possibly explains why spending almost 18% of GDP in healthcare does not result in
better health outcome than other developed countries.
For future policy development, our results show that it will be more beneficial to
focus on increasing the number of physicians. Having more physicians per 1000
populations would be the best way to enhance the population health. In addition, since the
United States falls at the bottom in terms of health outcome, studying and implementing
good practices of all the other countries included in this study will help to improve health
outcome.

Appendix A: Variable Description and Data Source
Variable

Description

Data source

Life
Expectancy
Infant Mortality

Life expectancy at birth.

OECD

Mortality under age 1.

OECD

Infant Mortality
under 5
Public Health
Expenditure
Private Health
Expenditure
Income per
Capita
Physician

Mortality under age 5.

WDI

Health spending by
Government/compulsory per capita.
Voluntary and out-of-pocket health
spending per capita.
Gross National Income per capita.

OECD

Number of medical doctors per 1,000
inhabitants.

OECD

Acronym

OECD
OECD

Appendix B: Variables and Expected Signs
Variable Description

Expected under Life
Expectancy, Infant
Mortality, and Infant
Mortality under 5,
respectively

LifeExpectancy

Life Expectancy

Dependent Vaiable

InfantMortality

Infant Mortality

Dependent Vaiable

Mortality_Under _5

Infant Mortality under 5

Dependent Vaiable

PublicHealthExpenditure

Public Health Expenditure

+/-/-

PrivateHealthExpenditure

Private Health Expenditure

+/-/-

PerCapitaIncome

Income per Capita

+/-/-

Physician

Physician per 1,000 in habitants

+/-/-

Sources
Cosgrove, L. (2018). Healthcare comparison between U.S. and Switzerland. Meidum.
https://medium.com/@lilycosgrove/healthcare-comparison-between-u-s-andswitzerland-780e70081a26
de Cos, P., H. & Moral-Benito, E. (2011). Health care expenditure in the oecd countries:
efficiency and regulation. Banco de España;Occasional Papers Homepage.
Occasional Papers 1107
https://www.bde.es/f/webbde/SES/Secciones/Publicaciones/PublicacionesSeriada
s/Documento sOcasionales/11/Fich/do1107e.pdf
Joumard, I., Andres, C., & Nicq, C. (2010). Health Care Systems: Efficiency and
Institutions. OECD Economics Department Working Papers. 769, Pp 18.
http://dx.doi.org/10.1787/5kmfp51f5f9t-en
Miller, L., J., Lu, W. (2018). These are the Economics with the Most (and Least)
Efficient Health Care. Bloomberg.
https://www.bloomberg.com/news/articles/2018-09- 19/u-s-near-bottom-of-healthindex-hong-kong-and-singapore-at-top
Mirmirani, S., and Lippmann, M. (2011). Health care system efficiency analysis of G12
countries. International Business & Economics Research Journal 2011; 3
Peterson-Kaiser (2018). Percent insured. Health System Tracker.
https://www.healthsystemtracker.org/indicator/access-affordability/percentinsured/
Raeesi, P., Harati-Khalilabad, T., Rezapour, A., Azari, S., & Javan-Noughabi, J. (2018).
Effects of private and public health expenditure on health outcomes among
countries with different health care systems: 2000 and 2014. Medical journal of
the Islamic Republic of Iran, 32, 35. doi:10.14196/mjiri.32.35
Rahman, M. M., Khanam, R., & Rahman, M. (2018). Health care expenditure and health
outcome nexus: new evidence from the SAARC-ASEAN region. Globalization
and health, 14(1), 113. doi:10.1186/s12992-018-0430-1
Tacke, T. & Waldmann, R., J. (2011). The Relative Efficiency of Public and Private Health Care.
CEIS Tor Vergata. Research Paper Series. Vol. 9 Issue 8, No. 202.

ftp://www.ceistorvergata.it/repec/rpaper/RP202.pdf

World Health Organization, Organisation for Economic Co-operation and Development,
and The World Bank. (2018). Delivering quality health services: a global
imperative for universal health coverage. Creative Commons.
https://openknowledge.worldbank.org/bitstream/handle/10986/29970/127816.pdf
?sequence=4

